A dose-controlled study of 153Sm- ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases

European Journal of Cancer

Volumn 33, Issue 10, 1997, Pages 1583-1591

  Resche, I ^a   Chatal, J F ^a   Pecking, A ^b   Ell, P ^c   Duchesne, G ^c   Rubens, R ^d   Fogelman, I ^d   Houston, S ^d   Fauser, A ^e   Fischer, M ^f   Wilkins, D ^g  

^a CENTRE RENÉ GAUDUCHEAU   (France)

^b CENTRE RENÉ HUGUENIN   (France)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^d GUY S HOSPITAL   (United Kingdom)

^e Klin fur Hamatologie/Onkologie   (France)

^f KLINIKUM KASSEL   (Germany)

^g Wilkins Biomedical   (France)

Author keywords

153Sm EDTMP; Bone metastases; Pain relief; Systemic treatment

Indexed keywords

LEXIDRONAM SAMARIUM SM 153;

ADULT; AGED; ARTICLE; BONE MARROW TOXICITY; BONE METASTASIS; BONE PAIN; CANCER PAIN; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PRIORITY JOURNAL; RADIATION DOSE;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, NON-NARCOTIC; BONE NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; ORGANOPHOSPHORUS COMPOUNDS; PALLIATIVE CARE; PLATELET COUNT; RADIOISOTOPES; SAMARIUM; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0031417685     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00155-X     Document Type: Article

References (19)

1. Tong D, Gillick L, Hendrickson FR. The palliation of symptomatic osseous metastases. Cancer 1982, 50, 893-899.
2. Salazar OM, Rubin P, Hendrickson FR, et al. Single-dose half-body irradiation for palliation of multiple bone metastases from solid tumors. Cancer 1986, 58, 29-36.
3. Averbuch S. New bisphosphonates in the treatment of bone metastases. Cancer 1993, 72, 3443-3452.
4. Coleman RE. Bisphosphonate treatment of bone metastases and hypercalcemia of malignancy. Oncology 1991, 5, 55-62.
5. Conte PF, Latreille J, Mauriac L, et al. Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. J Clin Oncol 1996, 14, 2552-2559.
6. Serafini AN. Current status of systemic intravenous radiopharmaceuticals for the treatment of painful metastatic bone disease. Int J Radiat Oncol Biol Phys 1994, 30, 1187-1194.
7. Laing AH, Ackery DM, Bayly RJ, et al. Strontium-89 chloride for pain palliation in prostatic skeletal malignancy. Br J Radiol 1991, 64, 816-822.
8. Lewington VJ. Targeted radionuclide therapy for bone metastases. Eur J Nucl Med 1993, 20, 66-74.
9. Eary JF, Collins C, Stabin M, et al. Samarium-153-EDTMP biodistribution and dosimetry estimation. J Nucl Med (7) 1993, 34, 1031-1036.
10. Goeckeler WF, Edwards B, Volkert WA, et al Skeletal localization of Samarium-153 chelates: potential therapeutic bone agents. J Nucl Med 1987, 28, 495-504.
11. Goeckeler WF. Sm-153 complexes as radiotherapeutic bone agents. Ph.D. Dissertation. University of Missouri-Columbia, 1984.
12. Singh A, Holmes RA, Farhangi M, et al. Human pharmacokinetics of samarium-153 EDTMP in metastatic cancer. J Nucl Med 1989, 30, 1814-1818.
13. Schlien B, Terpilak MS, eds. The Health Physcics and Radiological Health Handbook. Olney, Maryland, Nucleon Lectern Associates Inc., 1984.
14. Turner JH, Claringbold PG, Hetherington EL, et al. A phase I study of samarium-153 ethylenediaminetetramethylene phosphonate therapy for disseminated skeletal metastases. J Clin Oncol (12) 1989, 7, 1926-1931.
15. Farhangi M, Holmes RA, Volkert WA, et al. Samarium-153-EDTMP: pharmacokinetic, toxicity and pain response using an escalating dose schedule in treatment of metastatic bone cancer. J Nucl Med 1992, 33, 1451-1458.
16. Collins C, Eary JF, Vernon C, et al Samarium-153 EDTMP in the treatment of prostate carcinoma: a phase I/II trial. J Nucl Med 1993, 34, 1839-1844.
17. Karnofsky DA. Meaningful clinical classification of therapeutic responses to anti-cancer drugs. Clin Pharm Ther 1961, 709-712.
18. Donaldson G. A new approach to calculating pain measurements for cancer patients. Sci Comput Automation 1992, January, 45-48.
19. Langmuir VK, Sutherland RM. Radiobiology and radioimmunotherapy: current status. Antibody Immunoconj Radiopharm 1988, 1, 195-211.